Suppr超能文献

血管内皮生长因子D对淋巴系统的发育并非必需。

Vascular endothelial growth factor D is dispensable for development of the lymphatic system.

作者信息

Baldwin Megan E, Halford Michael M, Roufail Sally, Williams Richard A, Hibbs Margaret L, Grail Dianne, Kubo Hajime, Stacker Steven A, Achen Marc G

机构信息

Ludwig Institute for Cancer Research, Royal Melbourne Hospital, PO Box 2008, Parkville, Victoria 3050, Australia.

出版信息

Mol Cell Biol. 2005 Mar;25(6):2441-9. doi: 10.1128/MCB.25.6.2441-2449.2005.

Abstract

Vascular endothelial growth factor receptor 3 (Vegfr-3) is a tyrosine kinase that is expressed on the lymphatic endothelium and that signals for the growth of the lymphatic vessels (lymphangiogenesis). Vegf-d, a secreted glycoprotein, is one of two known activating ligands for Vegfr-3, the other being Vegf-c. Vegf-d stimulates lymphangiogenesis in tissues and tumors; however, its role in embryonic development was previously unknown. Here we report the generation and analysis of mutant mice deficient for Vegf-d. Vegf-d-deficient mice were healthy and fertile, had normal body mass, and displayed no pathologic changes consistent with a defect in lymphatic function. The lungs, sites of strong Vegf-d gene expression during embryogenesis in wild-type mice, were normal in Vegf-d-deficient mice with respect to tissue mass and morphology, except that the abundance of the lymphatics adjacent to bronchioles was slightly reduced. Dye uptake experiments indicated that large lymphatics under the skin were present in normal locations and were functional. Smaller dermal lymphatics were similar in number, location, and function to those in wild-type controls. The lack of a profound lymphatic phenotype in Vegf-d-deficient mice suggests that Vegf-d does not play a major role in lymphatic development or that Vegf-c or another, as-yet-unknown activating Vegfr-3 ligand can compensate for Vegf-d during development.

摘要

血管内皮生长因子受体3(Vegfr - 3)是一种酪氨酸激酶,在淋巴管内皮细胞上表达,可发出淋巴管生长信号(淋巴管生成)。Vegf - d是一种分泌型糖蛋白,是已知的Vegfr - 3的两种激活配体之一,另一种是Vegf - c。Vegf - d刺激组织和肿瘤中的淋巴管生成;然而,其在胚胎发育中的作用此前尚不清楚。在此,我们报告了Vegf - d基因缺陷型突变小鼠的产生和分析。Vegf - d基因缺陷型小鼠健康且可育,体重正常,未表现出与淋巴功能缺陷一致的病理变化。在野生型小鼠胚胎发育过程中Vegf - d基因强烈表达的肺部,Vegf - d基因缺陷型小鼠的肺在组织质量和形态方面正常,只是细支气管附近的淋巴管数量略有减少。染料摄取实验表明,皮肤下的大淋巴管位置正常且功能正常。较小的真皮淋巴管在数量、位置和功能上与野生型对照相似。Vegf - d基因缺陷型小鼠缺乏明显的淋巴表型,这表明Vegf - d在淋巴发育中不发挥主要作用,或者Vegf - c或另一种尚未知晓的激活Vegfr - 3的配体在发育过程中可以补偿Vegf - d的作用。

相似文献

1
Vascular endothelial growth factor D is dispensable for development of the lymphatic system.
Mol Cell Biol. 2005 Mar;25(6):2441-9. doi: 10.1128/MCB.25.6.2441-2449.2005.
4
Molecular control of lymphatic metastasis.
Ann N Y Acad Sci. 2008;1131:225-34. doi: 10.1196/annals.1413.020.
7
Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Anat Rec (Hoboken). 2008 Oct;291(10):1227-35. doi: 10.1002/ar.20736.
8
Tumor-induced lymphangiogenesis: a target for cancer therapy?
J Biotechnol. 2006 Jun 25;124(1):224-41. doi: 10.1016/j.jbiotec.2006.01.007. Epub 2006 Feb 23.
9
Deficiency of vascular endothelial growth factor-D does not affect murine adipose tissue development.
Biochem Biophys Res Commun. 2009 Jan 9;378(2):255-8. doi: 10.1016/j.bbrc.2008.11.032. Epub 2008 Nov 18.

引用本文的文献

1
Strategies for the vascular patterning of engineered tissues for organ repair.
Nat Biomed Eng. 2025 Jun 20. doi: 10.1038/s41551-025-01420-w.
2
Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives.
Signal Transduct Target Ther. 2025 May 19;10(1):170. doi: 10.1038/s41392-025-02249-0.
3
Epicardial VEGFC/D signaling is essential for coronary lymphangiogenesis.
EMBO Rep. 2025 Mar 24. doi: 10.1038/s44319-025-00431-7.
4
Beyond vessels: unraveling the impact of VEGFs on neuronal functions and structure.
J Biomed Sci. 2025 Mar 6;32(1):33. doi: 10.1186/s12929-025-01128-8.
5
Vascular Endothelial Growth Factor (VEGF) and Its Role in the Cardiovascular System.
Biomedicines. 2024 May 10;12(5):1055. doi: 10.3390/biomedicines12051055.
6
Toward Characterizing Lymphatic Vasculature in the Mammary Gland During Normal Development and Tumor-Associated Remodeling.
J Mammary Gland Biol Neoplasia. 2024 Jan 13;29(1):1. doi: 10.1007/s10911-023-09554-w.
7
Vascular Endothelial Growth Factor-D (VEGF-D): An Angiogenesis Bypass in Malignant Tumors.
Int J Mol Sci. 2023 Aug 28;24(17):13317. doi: 10.3390/ijms241713317.
9
Expansion and collapse of VEGF diversity in major clades of the animal kingdom.
Angiogenesis. 2023 Aug;26(3):437-461. doi: 10.1007/s10456-023-09874-9. Epub 2023 Apr 5.
10
Breaking a Vicious Circle: Lymphangiogenesis as a New Therapeutic Target in Wound Healing.
Biomedicines. 2023 Feb 21;11(3):656. doi: 10.3390/biomedicines11030656.

本文引用的文献

3
Angiogenic responses of vascular endothelial growth factors in periadventitial tissue.
Hum Gene Ther. 2003 Oct 10;14(15):1451-62. doi: 10.1089/104303403769211664.
4
Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D.
J Exp Med. 2003 Sep 15;198(6):863-8. doi: 10.1084/jem.20030361. Epub 2003 Sep 8.
5
VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
Circ Res. 2003 May 30;92(10):1098-106. doi: 10.1161/01.RES.0000073584.46059.E3. Epub 2003 Apr 24.
7
Molecular control of lymphangiogenesis.
Bioessays. 2002 Nov;24(11):1030-40. doi: 10.1002/bies.10173.
9
Lymphangiogenesis and cancer metastasis.
Nat Rev Cancer. 2002 Aug;2(8):573-83. doi: 10.1038/nrc863.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验